Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells - PubMed (original) (raw)
. 1998 Sep 15;161(6):2833-40.
Affiliations
- PMID: 9743343
Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
T S Griffith et al. J Immunol. 1998.
Abstract
The observation that TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF cytokine family, induces apoptosis in a number of different tumor cell types led us to compare the tumoricidal effects of TRAIL to those of other TNF family molecules on human melanoma cells. We found that a high proportion of the melanoma cell lines tested were killed by TRAIL, whereas all the melanoma lines were resistant to the other TNF family cytokines tested. TRAIL-induced death was characterized by caspase activation and cellular protein cleavage within minutes of TRAIL addition, and death could be completely inhibited by the caspase inhibitors Ile-Glu-Thr-Asp (IETD) and Val-Ala-Asp (VAD), indicating the presence of a TRAIL receptor signaling pathway similar to that identified for Fas and TNF receptors. Specific TRAIL receptor expression was determined by RT-PCR, and the presence of mRNA encoding the "protective" TRAIL receptors did not correspond to resistance or sensitivity to TRAIL-induced apoptosis. Addition of protein synthesis inhibitors to TRAIL-resistant melanomas rendered them sensitive to TRAIL, indicating that the presence or the absence of intracellular apoptosis inhibitors may mediate resistance or sensitivity to TRAIL-mediated apoptosis. Expression of one such inhibitor, FLICE-inhibitory protein (FLIP), was highest in the TRAIL-resistant melanomas, while being low or undetectable in the TRAIL-sensitive melanomas. Furthermore, addition of actinomycin D to TRAIL-resistant melanomas resulted in decreased intracellular concentrations of FLIP, which correlated with their acquisition of TRAIL sensitivity. Collectively, our results indicate that TRAIL-induced apoptosis occurs through a caspase signaling cascade and that resistance is controlled by intracellular regulators of apoptosis.
Similar articles
- FLIP protein and TRAIL-induced apoptosis.
Roth W, Reed JC. Roth W, et al. Vitam Horm. 2004;67:189-206. doi: 10.1016/S0083-6729(04)67011-7. Vitam Horm. 2004. PMID: 15110178 Review. - Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L, Fang B. Zhang L, et al. Cancer Gene Ther. 2005 Mar;12(3):228-37. doi: 10.1038/sj.cgt.7700792. Cancer Gene Ther. 2005. PMID: 15550937 Review.
Cited by
- Combining trail with PI3 kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling.
Saturno G, Valenti M, De Haven Brandon A, Thomas GV, Eccles S, Clarke PA, Workman P. Saturno G, et al. Oncotarget. 2013 Aug;4(8):1185-98. doi: 10.18632/oncotarget.1162. Oncotarget. 2013. PMID: 23852390 Free PMC article. - Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells.
Akhmetzyanova I, Zelinskyy G, Schimmer S, Brandau S, Altenhoff P, Sparwasser T, Dittmer U. Akhmetzyanova I, et al. Cancer Immunol Immunother. 2013 Feb;62(2):257-71. doi: 10.1007/s00262-012-1329-y. Epub 2012 Aug 14. Cancer Immunol Immunother. 2013. PMID: 22890822 Free PMC article. - Antiproliferative and Apoptotic Effect of Curcumin and TRAIL (TNF Related Apoptosis inducing Ligand) in Chronic Myeloid Leukaemic Cells.
Iqbal B, Ghildiyal A, Sahabjada, Singh S, Arshad M, Mahdi AA, Tiwari S. Iqbal B, et al. J Clin Diagn Res. 2016 Apr;10(4):XC01-XC05. doi: 10.7860/JCDR/2016/18507.7579. Epub 2016 Apr 1. J Clin Diagn Res. 2016. PMID: 27190933 Free PMC article. - Association between TRAIL gene polymorphisms and the susceptibility and severity of lumbar disc degeneration.
Du H, Bai B, Qiu Y, Yin S, Bian W. Du H, et al. Int J Clin Exp Pathol. 2015 Jun 1;8(6):7415-20. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261645 Free PMC article. - The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.
Wallace ME, Smyth MJ. Wallace ME, et al. Springer Semin Immunopathol. 2005 Jun;27(1):49-64. doi: 10.1007/s00281-004-0195-x. Epub 2005 Feb 24. Springer Semin Immunopathol. 2005. PMID: 15729567 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous